CyberKnife Treatment: Image-Guided Stereotactic Radiotherapy

CyberKnife treatment is a non-invasive form of image-guided stereotactic radiotherapy that delivers highly focused radiation to selected tumors and other lesions. It may be used in the brain, spine, lung, prostate, liver and other areas when a specialist team considers it appropriate.

Overview

CyberKnife treatment is a type of stereotactic radiotherapy delivered by a robotic radiation system. Despite its name, it is not a knife and it does not involve an incision. Instead, it uses many small, carefully shaped radiation beams that meet at the target, allowing a high dose to be delivered to the lesion while helping to limit exposure to nearby healthy tissues.

The technology combines a compact linear accelerator, a robotic arm and image-guidance software. During treatment, repeated imaging checks the position of the target. The robotic arm can adjust the radiation beam from many angles, which is especially useful for tumors near sensitive structures or for targets that move with breathing.

CyberKnife is one form of stereotactic radiosurgery or stereotactic body radiotherapy. The term radiosurgery is often used when treatment is delivered to the brain or spine, while stereotactic body radiotherapy is commonly used for tumors in the lung, liver, prostate, pancreas and other body sites. A radiation oncologist decides which term and approach apply to each patient.

How CyberKnife Treatment Works

CyberKnife treatment is planned with high-resolution imaging, usually including CT scans and, depending on the condition, MRI, PET-CT or other studies. These images help the medical team define the treatment target and nearby organs that need protection. A personalized treatment plan is then created using specialized software.

During each session, the patient lies on a treatment table while the robotic arm moves around the body. The system delivers radiation from multiple directions rather than from a single fixed angle. This approach helps concentrate the dose where it is needed and reduce unnecessary dose to surrounding tissues.

A key feature is image guidance during treatment. X-ray images or other tracking methods compare the current position of the target with the treatment plan. If the patient moves slightly, or if a target changes position with normal breathing, the system can adjust beam delivery according to the planned safety limits.

Most CyberKnife treatments are completed as outpatient care. The session itself is painless, and patients usually do not feel radiation being delivered. Depending on the treatment site and plan, a course may involve a single session or several sessions over a few days.

Conditions That May Be Treated

CyberKnife may be considered for selected malignant and benign tumors, as well as some functional conditions. It is often discussed when a target is small or well-defined, when surgery is not preferred or not possible, or when a highly focused radiation approach may be helpful. However, it is not suitable for every tumor or every patient.

Common treatment areas may include brain tumors, brain metastases, acoustic neuromas, meningiomas, spine tumors, certain lung tumors, prostate cancer, liver tumors, pancreatic tumors and kidney tumors. In some centers, stereotactic radiosurgery may also be used for conditions such as arteriovenous malformations or trigeminal neuralgia, depending on local expertise and patient factors.

Suitability depends on several clinical details, including:

• The type of tumor or lesion and whether it is cancerous or benign
• The size, shape and exact location of the target
• How close the lesion is to the spinal cord, optic nerves, bowel, bladder or other sensitive organs
• Whether the patient has had previous surgery, radiotherapy, chemotherapy or immunotherapy
• The patient’s symptoms, general health and treatment goals

For some patients, CyberKnife is used as the main treatment. For others, it may be part of a broader plan that includes surgery, conventional radiotherapy, chemotherapy, targeted therapy, hormone therapy or active monitoring. Decisions are best made through a multidisciplinary review.

Benefits and Limitations

The main advantage of CyberKnife treatment is precision. Because the system uses robotic beam delivery and image guidance, it can deliver radiation from many directions with careful targeting. This may help treat lesions in challenging locations, especially where sparing nearby healthy tissue is important.

For many patients, the treatment is convenient because it is non-invasive and usually performed without hospitalization. There is no surgical wound, no general anesthesia in most cases and no typical recovery period associated with an operation. Many people return to routine daily activities soon after treatment, although this depends on the treated area and individual health.

CyberKnife also has limitations. It may not be appropriate for very large tumors, widespread disease that needs a different treatment strategy, or lesions too close to organs that cannot safely receive the required dose. In some situations, conventional radiotherapy, surgery, systemic therapy or a combination approach may offer a better balance of benefits and risks.

It is also important to understand that results are not always immediate. Radiation works by damaging the DNA of targeted cells, which may stop growth or cause gradual shrinkage over time. Follow-up imaging is usually needed to assess response, and the timing of response varies by diagnosis.

Planning and What to Expect

Before treatment, the patient meets with a radiation oncologist and often other specialists, such as a neurosurgeon, medical oncologist, urologist or radiologist. The team reviews the diagnosis, previous tests, medical history and treatment options. If CyberKnife is appropriate, a simulation appointment is scheduled to prepare the treatment plan.

During simulation, the patient is positioned in a way that can be reproduced accurately during treatment. A custom mask may be used for brain or head and neck treatments, while a comfortable body support may be used for chest, abdomen or pelvis treatments. Some prostate or body treatments may require small markers called fiducials to be placed near the target, although not all cases need them.

The planning process may take several days because the team carefully outlines the tumor and surrounding organs on imaging scans. Medical physicists and dosimetrists help design a plan that meets the prescribed dose while respecting safety limits. The radiation oncologist reviews and approves the final plan before treatment begins.

On treatment day, the patient is positioned on the table, and the care team monitors the session from outside the room using cameras and communication systems. The patient should remain as still as possible, but normal breathing is expected. The total time in the treatment room varies, and the team explains the schedule in advance.

Possible Side Effects and Recovery

CyberKnife treatment is generally well tolerated, but side effects can occur. They depend mainly on the area treated, the dose, the number of sessions, previous treatments and the patient’s individual sensitivity. The care team explains expected side effects and warning signs before treatment.

Some patients feel tired for a short period after treatment. Skin irritation is uncommon with many stereotactic treatments but may occur in certain treatment areas. Brain treatments may cause temporary headache, nausea or swelling-related symptoms, while lung treatment may cause cough or mild chest discomfort. Prostate treatment may cause urinary frequency, urgency or bowel changes for some patients.

Less common but more serious side effects are related to injury or inflammation in nearby normal tissues. For example, treatment near the brain, spinal cord, bowel, lung or optic pathways requires careful planning and follow-up. The team uses dose constraints and image guidance to reduce these risks, but no radiation treatment is completely risk-free.

Recovery advice is personalized. Patients are usually encouraged to rest if tired, maintain hydration and nutrition, and follow medication instructions if prescribed. Follow-up visits and imaging are important because they help the doctor evaluate response, manage side effects and plan any additional care if needed.

Follow-Up, Self-Care and When to See a Doctor

After CyberKnife treatment, follow-up is part of care rather than an optional step. Imaging may be scheduled weeks or months later, depending on the condition. In some tumors, the first signs of response are stabilization rather than shrinkage, so results should be interpreted by the treating specialist.

Patients can support recovery by keeping appointments, reporting new symptoms and sharing all medications and supplements with the care team. Healthy routines such as balanced nutrition, gentle activity when approved, adequate sleep and smoking cessation can support general well-being during cancer or tumor care.

A doctor should be contacted promptly if symptoms are new, persistent or worsening. Examples include severe headache, new weakness, seizures, shortness of breath, fever, increasing pain, significant urinary or bowel problems, confusion, vision changes or any symptom the treatment team identified as important for that patient.

International patients who are considering image-guided stereotactic radiotherapy can seek evaluation from centers with experienced multidisciplinary teams. Acibadem International’s specialists and JCI-accredited hospitals diagnose and treat selected conditions with CyberKnife and other radiotherapy technologies, with treatment decisions tailored to each patient’s medical needs.

Frequently asked questions

Is CyberKnife treatment the same as surgery?

No. CyberKnife treatment is a form of radiation therapy, not an operation. It does not involve a surgical incision, and most patients do not need general anesthesia.

How many CyberKnife sessions are usually needed?

The number of sessions depends on the diagnosis, target size, location and treatment plan. Some treatments are delivered in one session, while others are given over several sessions, commonly within a short course.

Does CyberKnife treatment hurt?

The treatment itself is painless because radiation cannot be felt as it is delivered. Some patients may feel discomfort from lying still or from the positioning device, but the team can help improve comfort.

When will the results be known?

Results vary by condition and may take weeks to months to become clear on follow-up imaging. In some cases, the goal is to stop growth rather than to make the tumor disappear immediately.

Can CyberKnife be used after previous radiotherapy?

Sometimes it can, but this requires careful review. The doctor must consider the previous radiation dose, the time since treatment and the tolerance of nearby organs before recommending another course.

Who decides if CyberKnife is appropriate?

A radiation oncologist evaluates whether CyberKnife is suitable, often together with surgeons, medical oncologists, radiologists and other specialists. The decision is based on the diagnosis, imaging, treatment goals and the patient’s overall health.

References

• American Society for Radiation Oncology
• National Cancer Institute
• European Society for Radiotherapy and Oncology
• International Atomic Energy Agency
• American College of Radiology

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.